MLN4924 (pevonedistat), which is a selective inhibitor of the NEDD8-activating enzyme (NAE), has been shown to destabilize SREBP1 and suppress lipogenesis, tumor growth, and invasiveness in vitro and in vivo [84]. This evidence concerns the gene SREBF1 and neoplasm.